Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Appendix B Workshop Speakers Jeff Abrams, National Cancer Institute Laurence Baker, Southwest Oncology Group and the University of Michigan Al Benson� Robert H. Lurie Comprehensive Cancer Center , Gordon Bernard, Vanderbilt University Jan Buckner, Mayo Clinic Robert Califf, Duke University Michael Caligiuri� Ohio State University Comprehensive Cancer Center , Renzo Canetta� BristolâMyers Squibb , Deborah Collyar, Patient Advocates in Research Robert Comis, Coalition of National Cancer Cooperative Groups Walter Curran, Winship Cancer Institute David Dilts, Vanderbilt University James Doroshow, National Institutes of Health John Feldmann, Moses Cone Regional Cancer Center Leslye Fitterman, Centers for Medicare and Medicaid Services Gwendolyn Fyfe, Genentech Stephen Grubbs, Christiana Care Community Clinical Oncology Program Richard Kaplan, National Cancer Research Network in the United Kingdom Alan Keller, US Oncology, Cancer Care Associates Allen Lichter, American Society of Clinical Oncology Maurie Markman, M. D. Anderson Comprehensive Cancer Center 117
118 MULTI-CENTER PHASE III CLINICAL TRIALS Lee Newcomer, UnitedHealthcare John Niederhuber, National Cancer Institute Richard Pazdur� Food and Drug Administration , Richard Schilsky, University of Chicago Marcy Waldinger, University of Michigan Comprehensive Cancer Center